OTC/SmallCap IRW

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...

2021-02-22 15:03 7026

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 6169

Crunchfish enrolled to leading international payment network's partner program

STOCKHOLM, Feb. 18, 2021 /PRNewswire/ -- Crunchfish AB ("Crunchfish") announces its enrolment into a leading international payment network's partner program with its Digital Cash solutions. As a technology partner, Crunchfish will get access to specifications and toolkits enabling integration wit...

2021-02-18 16:12 8074

Nel ASA: Fourth quarter 2020 financial results

OSLO, Norway, Feb. 18, 2021 /PRNewswire/ -- Nel ASA (Nel) reported revenues of NOK 229.1 million in the fourth quarter of 2020, up from NOK 175.9 million in the same quarter of 2019 and an EBITDA of negativeNOK 96.2 million (Q4 2019: -41.7) incl. one-offs, ramp-up cost and aNOK 20 million provisi...

2021-02-18 14:59 5768

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

2021-02-17 20:00 4403

Notice convening the Annual General Meeting of AB Electrolux

STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- The shareholders of AB Electrolux, reg. no. 556009-4178, are hereby given notice of the Annual General Meeting to be held onThursday, March 25, 2021. Due to the coronavirus, the Board of Directors has decided that the Annual General Meeting should be cond...

2021-02-15 20:42 5814

Digital Cash enables global interoperability for payment services

STOCKHOLM, Feb. 15, 2021 /PRNewswire/ -- Crunchfish is a technical pioneer within digital payment with Digital Cash that settles payments in two steps, first offline and then online. This enables payments that always work and can also be made with preserved integrity. Digital Cash is extremely fl...

2021-02-15 20:26 7768

Össur will be carbon neutral in 2021

REYKJAVIK, Iceland, Feb. 10, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, announced today that the company will be carbon neutral in 2021, its 50th anniversary year. Originally founde...

2021-02-10 23:58 7330

BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines

VANCOUVER, BC and BARCELONA, Spain, Feb. 10, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC:L MNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, and Procare Health Iberia, S.L., ofBarcelona, Spain ("Procare Health"...

2021-02-10 21:26 7576

Elekta's ProKnow to help standardize radiotherapy for veterans

Cloud-based ProKnow will enable peer review across Veterans Affairs network ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with El...

2021-02-10 21:25 6663
1 ... 4445464748